
News|Articles|May 1, 2002
Stavudine: Lactic acidosis, motor weakness warnings
Bristol-Myers Squibb has issued a "Dear Healthcare Provider" letter and revised labeling to inform of the potential for lactic acidosis and severe hepatomegaly with steatosis-including some fatal cases-when nucleoside analogue therapy is used alone or in combination with other antiretrovirals
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Real-World Data Shows Vision Decline as Copay Programs Run Dry | AAO 2025
2
AI and Ophthalmology: A Nearly Picture Perfect Kinda Match | AAO 2025
3
El Niño and La Niña Affect Eye Health Too, Not Just Weather | AAO 2025
4
In Complement Inhibition Debate, Game Change Goes Against Too Little, Too Late | AAO 2025
5